Guidelines

• NCCN Guidelines Version 3.2022

Evidence Blocks

• NCCN Guidelines with Evidence Blocks Version 3.2022

Frameworks

• Basic Resources (English) Version 3.2020 (Preliminary)

• Core Resources (English) Version 3.2020 (Preliminary)

• Enhanced Resources (English) Version 3.2020 (Preliminary)

Guidelines for Patients

• Invasive Breast Cancer-English Version 2022

• Metastatic Breast Cancer-English Version 2022

• DCIS Breast Cancer-English Version 2022

• Metastatic Breast Cancer-French Canadian Version 2018

• Invasive Breast Cancer-French Canadian Version 2018

• DCIS Breast Cancer-French Canadian Version 2018

• Invasive Breast Cancer-Russian Version 2018

• Metastatic Breast Cancer-Russian Version 2018

• DCIS Breast Cancer-Russian Version 2018

• Metastatic Breast Cancer-Ukrainian Version 2020

• DCIS Breast Cancer-Ukrainian Version 2020

• Invasive Breast Cancer-Ukrainian Version 2020

Educational Events and Programs

Calendar of Events

Continuing Education

• Archived Monthly Oncology Tumor Boards: Brain Metastases in Breast Cancer

• Clinical Scenario #2: Applying Biomarkers in Metastatic Breast Cancer

• Clinical Scenario #4: Evolving Applications of PARP Inhibitors in Various Cancers

• Genetic/Familial Risk Assessment for Breast Cancer: Testing Considerations and Controversies

• Impact of the Pandemic on Breast Cancer Screening

• Surgical Management of Non-Metastatic Breast Cancer with SABCS Updates

• Radiation Therapy for Non-Metastatic Breast Cancer with SABCS Updates

• Neoadjuvant and Adjuvant Treatment for Breast Cancer with SABCS Updates

• Management of Metastatic Breast Cancer with SABCS Updates

• Managing Pain and Neuropathy in Breast Cancer Survivors

International

Disclosures

• Disclosure Policy

• Panel Member Disclosures

• Panel Member Disclosures by Meeting Date

• End User License Agreement